CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

3.220

+0.060 (1.90%)

At close: Jun 3, 2026, 4:00 PM EDT

3.210

-0.010 (-0.31%)

After-hours: Jun 3, 2026, 4:55 PM EDT

CytomX Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	35.54	76.2	138.1	101.21	53.16	37.31
Revenue Growth (YoY)	-75.91%	-44.82%	36.45%	90.38%	42.48%	-45.47%
Gross Profit	35.54	76.2	138.1	101.21	53.16	37.31
Selling, General & Admin	31.1	29.84	29.73	30.02	42.85	39.16
Research & Development	69.1	68.73	83.38	77.68	111.65	114.19
Total Operating Expenses	100.2	98.57	113.11	107.7	154.5	153.35
Operating Income	-64.66	-22.36	25	-6.48	-101.34	-116.04
Interest Income	5.74	5.21	7.14	9.84	1.68	0.26
Other Non-Operating Income (Expense)	0.01	0.03	-0.04	-0.03	0.34	-0.08
Total Non-Operating Income (Expense)	5.75	5.23	7.1	9.81	2.02	0.17
Pretax Income	-58.91	-17.13	32.09	3.32	-99.32	-115.87
Provision for Income Taxes	0.23	0.24	0.22	3.89	-	-
Net Income	-40.89	-20.37	31.87	-0.57	-99.32	-115.87
Net Income Attributable to Preferred Dividends	-	3	-	-	-	-
Net Income to Common	-40.89	-20.37	31.87	-0.57	-99.32	-115.87
Shares Outstanding (Basic)	160	138	84	74	66	64
Shares Outstanding (Diluted)	159	138	85	74	66	64
Shares Change (YoY)	85.61%	62.77%	14.82%	12.27%	2.48%	39.01%
EPS (Basic)	-0.41	-0.15	0.38	-0.01	-1.51	-1.81
EPS (Diluted)	-0.41	-0.15	0.38	-0.01	-1.51	-1.81
Shares Outstanding	177.27	170.19	80.1	73.81	66.23	65.25
Free Cash Flow	-80.19	-75.81	-86.54	-56.88	-112.53	-120.64
Free Cash Flow Per Share	-0.50	-0.55	-1.02	-0.77	-1.71	-1.88
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-181.92%	-29.35%	18.10%	-6.41%	-190.61%	-311.00%
Profit Margin	-115.05%	-22.79%	23.08%	-0.56%	-186.82%	-310.54%
FCF Margin	-225.63%	-99.48%	-62.66%	-56.19%	-211.67%	-323.33%
EBITDA	-63.42	-20.99	26.76	-4.31	-98.89	-113.34
EBITDA Margin	-178.43%	-27.54%	19.38%	-4.26%	-186.02%	-303.75%
EBIT	-64.66	-22.36	25	-6.48	-101.34	-116.04
EBIT Margin	-181.92%	-29.35%	18.10%	-6.41%	-190.61%	-311.00%
Effective Tax Rate	-0.40%	-1.39%	0.70%	117.12%	0.00%	0.00%

SEC Filings: 10-K · 10-Q